Bio Sector Leads Korea’s Venture Recovery, but Structural Support Still Missing
Korea’s bio sector has emerged as the lone bright spot in an otherwise subdued venture market. Private investors are pouring ...
KoreaTechDesk | Korean Startup and Technology News
Korea’s bio sector has emerged as the lone bright spot in an otherwise subdued venture market. Private investors are pouring ...
SN Bioscience (CEO Park Yung-hwan) released the phase 1 clinical trial result on SNB-101, a new anticancer medicine pipeline, at ...